Table 2.
Cafeteria | GSPE Pre-Treated Rats | |
---|---|---|
Subcutaneous WAT | ||
Cpt1b | 1.03 ± 0.09 | 1.09 ± 0.12 |
Lipe | 0.94 ± 0.09 | 0.70 ± 0.05 # |
Fasn | 1.03 ± 0.09 | 0.74 ± 0.18 |
Dgat2 | 0.98 ± 0.08 | 0.90 ± 0.08 |
Cpt1b/Fasn (ratio between them) | 0.93 ± 0.06 | 1.40 ± 0.15 * |
Periovaric WAT | ||
Cpt1b | 1.01 ± 0.07 | 1.17 ± 0.05 |
Retroperitoneal WAT | ||
Cpt1b | 1.15 ± 0.20 | 1.27 ± 0.29 |
Fasn | 1.00 ± 0.08 | 0.95 ± 0.12 |
Dgat2 | 1.00 ± 0.05 | 0.99 ± 0.09 |
Cpt1b/Fasn (ratio between them) | 1.26 ± 0.24 | 1.56 ± 0.41 |
Mesenteric WAT | ||
Cpt1b | 1.05 ± 0.08 | 0.97 ± 0.1 |
Fasn | 0.95 ± 0.13 | 0.62 ± 0.1 # |
Dgat2 | 1.01 ± 0.09 | 0.78 ± 0.16 |
Cpt1b/Fasn (ratio between them) | 1.22 ± 0.27 | 1.50 ± 0.18 |
Reverse transcriptase-polymerase chain reaction (RT-PCR) was used for each gene (results are presented as arbitrary units versus cafeteria group, except detailed). The T test was used to determine statistical differences highlighted as * p < 0.05 vs. cafeteria treatment; # p < 0.1 vs. cafeteria group. Lipe (lipase E, hormone sensitive type).